1J Foley R N, Collins A J, Herzog C A, et al. Serum phosphorus lev- els associate with coronary atherosclerosis in young adults [J]. J Am Soe Nephml, 2009, 20(2):397-404. 被引量：1
3Lynch K E, Lynch R, Curhan G C, et al. Prescibed dietary phos- phate restriction and survivon among hemodialysis patients[J]. Clin J Am Soc Nephorl, 2010, 6(3):620-629,. 被引量：1
8Khalil A A, Darawad M A, Gamal E, et al. Predictors of dietary and fluid non -Adherence in Jordanian patients with end-stage renal disease receiving haemodialysis:A cross-sectional study[J]. Journal of Clinical Nursing, 2012, 22:127-136. 被引量：1
6Gutierrez OM,Mannstadt M,Isakova T,et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis[J]. N Engl J Med, 2008,359 (6) : 584-592. 被引量：1
7Cannata-Andia JB,Rodriguez-Garcia M. Hyperphosphatemia as a cardiovascular risk factor-how to manage the problem[J]. Nephrol Dial Transplant,2002,17 (suppl 11 ) : 16-19. 被引量：1
8Slatopolsky E. New developments in hyperphosphatemia management[J]. J Am Soc Nephrol,2003,14(9 suppl 4):297-299. 被引量：1
9Reddy V,Symes F,Sethi N,et al. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population [J]. J Ren Nutr,2009,19(4):314-320. 被引量：1
10Menon V,Greene T,Pereira AA,et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD[J]. Am J Kidney Dis, 2005,46 ( 3 ) : 455-463. 被引量：1
